Grown Rogue International (GRUSF) Receivables (2009 - 2026)
Grown Rogue International (GRUSF) posted quarterly Receivables of $3.2 million for Q1 2026, up 130.86% year-over-year from $1.4 million in Q1 2025, and up 1178.45% quarter-over-quarter from $253403.0 in Q4 2025.
Grown Rogue International (GRUSF) Receivables (2009 - 2026) Analysis & Trends
Grown Rogue International's Receivables history runs 18 years deep, the most recent figure standing at $3.2 million for Q1 2026.
- In Q1 2026, Receivables rose 130.86% year-over-year to $3.2 million; the TTM figure through Mar 2026 stood at $3.2 million (up 130.86% YoY), while the FY2025 annual figure was $2.9 million, up 154.41% from the prior year.
- Receivables for Q1 2026 stood at $3.2 million, up from $253403.0 in the prior quarter.
- The five-year high for Receivables was $2020.9 billion in Q3 2025, with the low at -$507424.0 in Q2 2024.
- The 5-year median for Receivables is $1.3 million (2022), against an average of $144.4 billion.
- The sharpest annual moves came in 2023 and 2025: Receivables tumbled 127.73% in 2023, then soared 103586638.4% in 2025.
- Grown Rogue International's Receivables stood at $1.2 million in 2022, then sank by 72.32% to $342612.3 in 2023, then surged by 233.66% to $1.1 million in 2024, then plunged by 77.83% to $253403.0 in 2025, then surged by 1178.45% to $3.2 million in 2026.
- Business Quant data shows GRUSF's Receivables at $3.2 million in Q1 2026, $253403.0 in Q4 2025, and $2020.9 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 1.08 Bn |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn | 3.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.68 Mn |
| Mar 31, 2026 | 3.24 Mn |
| Dec 31, 2025 | 253,403.00 |
| Sep 30, 2025 | 2,020.92 Bn |
| Jun 30, 2025 | -360,733.56 |
| Mar 31, 2025 | 1.40 Mn |
| Dec 31, 2024 | 1.14 Mn |
| Sep 30, 2024 | 1.95 Mn |
| Jun 30, 2024 | -507,423.97 |
| Mar 31, 2024 | 1.99 Mn |
| Dec 31, 2023 | 342,612.34 |
| Oct 31, 2023 | -343,277.59 |
| Jul 31, 2023 | 2.63 Mn |
| Jan 31, 2023 | 1.28 Mn |
| Oct 31, 2022 | 1.24 Mn |
| Oct 31, 2021 | -327,768.09 |
| Apr 30, 2021 | 372,663.00 |
| Jan 31, 2021 | 238,987.00 |
| Oct 31, 2020 | 175,621.00 |
| Jul 31, 2020 | 269,216.00 |